Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 764 of 1,261
  1. US 8974801

    Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

    Amphastar Pharmaceuticals, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  2. US 8974792

    Internalizing erbB2 antibodies

    The Regents of the University of California · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  3. US 8975014

    Fluorescence detection of poison oak oil

    The Regents of the University of California · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  4. US 8974776

    Biodegradable peptide releasing polymers

    Covidien LP · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  5. US 8975442

    Process for the preparation of and crystalline forms of optical enantiomers of modafinil

    Teva Sante · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  6. US 8975295

    Modulation of zinc levels to improve tissue properties

    Precision Dermatology, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  7. US 8975300

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted
  8. US 8968786

    Formation of stable submicron peptide or protein particles by thin film freezing

    The Board of Regents of the University of Texas System · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  9. US 8969571

    Biphenyl derivatives

    Theravance Respiratory Company, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  10. US 8969406

    Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same

    China Medical University · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  11. US 8969565

    Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  12. US 8969413

    Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

    Catalyst Pharmaceuticals, Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  13. US 8969388

    Substituted pyrazolone compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  14. US 8969387

    Pyrrole compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  15. US 8969403

    Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  16. US 8969386

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  17. US 8969360

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  18. US 8969370

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  19. US 8969367

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  20. US 8969340

    Methods for treating chronic pelvic pain syndrome

    Northwestern University · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  21. US 8969321

    Medical and nutritional applications of highly refined cellulose

    Regents of the University of Minnesota · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  22. US 8969293

    Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  23. US 8969292

    High affinity leptins and leptin antagonists

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  24. US 8969303

    Tocotrienol esters

    First Tech International Limited · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.